Wikidata

(Q53810640)

English

Results Of A Dutch Cost-Effectiveness Model Of Radium-223 In Comparison To Cabazitaxel, Abiraterone, And Enzalutamide In Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel.

scientific article

In more languages

Statements

title
Results Of A Dutch Cost-Effectiveness Model Of Radium-223 In Comparison To Cabazitaxel, Abiraterone, And Enzalutamide In Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Docetaxel. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26532581
retrieved
20 May 2018
reference URL
http://europepmc.org/abstract/MED/26532581

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53810640&oldid=1638559589"